Bionano’s Symposium 2023 Featured Record Numbers of Presentations Demonstrating Applications of OGM Across Cell Bioprocessing and Constitutional Genetic Disease and Cancer Research
Retrieved on:
Thursday, February 2, 2023
Columbia University Irving Medical Center, Disease management, Research, MD Anderson Cancer Center, Genomics, KT, Chromosome, SNV, OGM, Cancer, Multiple myeloma, SVS, FISH, HRD, TNBC, Curie Institute (Paris), Fluorescence, Hospital, Poster, WGS, University, Harvard Medical School, Medical college, Genome, NGS, Laboratory, Breast, Augusta University, SAN, Quality control, Potency (pharmacology), Neoplasm, Clinical trial, T-cell lymphoma, Sheba Medical Center, Workflow, Medical College of Georgia, Whole genome sequencing, Karyotype, In situ hybridization, Doctor of Philosophy, FACMG, Pharmaceutical industry, Medical device, Medical imaging, Vaccine, Microscope, Brigham, Genentech, VIA
During this four-day online event, presenters reported on their use of OGM for applications in genetic disease, cancer and cell bioprocessing.
Key Points:
- During this four-day online event, presenters reported on their use of OGM for applications in genetic disease, cancer and cell bioprocessing.
- OGM was highlighted by researchers as a high-performance, one-stop platform, potentially eliminating the need for multiple sequential testing.
- Aside from high concordance with classical cytogenetic methods, OGM produced additional relevant findings in 52% of all analyzed samples.
- (Day 2)
OGM has additional potential applications, including cell bioprocessing QC, in academic and commercial laboratory settings.